Adaptive Biotechnologies logo

Adaptive Biotechnologies

adaptivebiotech.comNasdaq: ADPT

Adaptive Biotechnologies works in biotech and pharma and is based in Seattle, WA. It was founded in 2009, has about 624 employees, and trades on Nasdaq as ADPT.

In its own words
Adaptive Biotechnologies is harnessing the immune system to unleash its power as a natural diagnostic and therapeutic tool to propel a paradigm shift in medicine.

Source: the company's website

Find the decision makers at Adaptive Biotechnologies

7-day free trial on every monthly plan. Card required.

You see who Rocketship finds once you sign up. Nothing is sent to anyone until you say so.

Who do you want to reach at Adaptive Biotechnologies?

Adaptive Biotechnologies has about 624 employees. Pick a team, and Rocketship searches for them live when you look. You see who it finds once you sign up. This page never lists anyone by name.

Why reach Adaptive Biotechnologies now

What changed lately, read from public records. Every number links to its source.

Hiring

19

open jobs

8 of them were posted in the last 30 days. Sales has 5 of them (26%).

Open jobs by teamOpenNew

new: posted in the last 30 daysopen longerPress a team to see its decision makers with Rocketship.

Newest openings

  • Scientist II, ValidationNov 20
  • Account Operations Manager (Northeast)Nov 19
  • Clinical Lab Technologist I/II/IIINov 19

Source: Adaptive Biotechnologies's Greenhouse job board, checked November 21, 2026

Your browser asks Greenhouse directly. Rocketship is not in between.

Government buyers

$38,880

new federal award, Sep 25

The Department of Health and Human Services gave Adaptive Biotechnologies a new award on Sep 25. 16 federal contract actions from 3 agencies in the last 12 months, under the SAM.gov registration that names adaptivebiotech.com.

Source: USAspending.gov, checked November 21, 2026

Revenue

+55%

revenue growth in FY2025

$179 million in FY2024 to $277 million in FY2025, from the annual report (10-K).

Source: SEC EDGAR, checked November 19, 2026

Budget timing

Dec 31

fiscal year end

Teams usually set next year's budgets in the months before the year ends.

Source: SEC EDGAR, checked November 17, 2026

Your way in at Adaptive Biotechnologies

Type what you sell. The page names the team that usually buys it here, what that team is doing now, and how many of its people Rocketship knows.

Matched on the word “sales”. A word list on this page picks the team. No AI reads what you type, and nothing leaves the page until you press the button.

Who usually buys “sales training” at Adaptive Biotechnologies

The sales team

Open jobs
52 new in 30 days, on their job board
People on this team
Searched liveRocketship looks when you press the button
Decision makers here
Searched liveRocketship looks when you press the button

Titles the button searches: Chief Revenue Officer, VP of Sales, Head of Sales, Sales Director.

Newest opening on this team: Account Operations Manager (Northeast), posted Nov 19.

Their inbox: mail passes Cisco Email Security first, so keep the first email plain text. How their email works

7-day free trial on every monthly plan. Card required.

Before you email Adaptive Biotechnologies

Read from adaptivebiotech.com's public DNS records on November 21, 2026. Anyone can check them; the records are at the end of this section.

Where mail lands first

Cisco Email Security

A mail filter: it checks every message before any inbox sees it.

What it means for you

Every message to Adaptive Biotechnologies passes Cisco Email Security before it reaches an inbox. A filter like this opens links and can load images to test them, so an open or a click from Adaptive Biotechnologies does not mean a person read your email.

  • Plain text, no attachment, and no more than one link.
  • Judge interest by replies, not by opens or clicks.
  • A few emails a day from a real inbox, not a burst from a new domain.

Rocketship writes in your voice, sends from your own Gmail and follows up on its own.

How do I send cold email without landing in spam?Why do my emails go to spam?

Domain lock (DMARC)

Set to none

Mail that pretends to come from this domain is only reported, not stopped. This is about mail sent as adaptivebiotech.com, not mail sent to it.

Verified with

  • Google
  • Miro
  • Apple
  • Atlassian
  • DocuSign
  • Postman
  • Anthropic
  • Adobe
  • Docker

Each service asked the domain to add a DNS record as proof of ownership. A record can stay after a service is dropped, and security tools are left off this list.

See the records this section reads
MX
mx1.hc5439-49.iphmx.commx2.hc5439-49.iphmx.com
SPF
v=spf1 redirect=5rzo7syg._spf._d.mim.ec
DMARC
v=DMARC1; p=none; fo=1

Check them yourself: nslookup -type=mx adaptivebiotech.com, nslookup -type=txt adaptivebiotech.com, nslookup -type=txt _dmarc.adaptivebiotech.com

Your browser asks Google Public DNS directly. Rocketship is not in between.

How Rocketship would reach Adaptive Biotechnologies

  1. Step 1

    Finds the right people

    You say who you want to reach. Rocketship finds them by title and researches each one before anything is written.

  2. Step 2

    Emails them from your own Gmail

    It writes in your voice, sends from your inbox and follows up on its own.

  3. Step 3

    Books the meeting

    When someone says yes, it offers times from your calendar and puts the meeting on it.

7-day free trial on every monthly plan. Card required.

Questions about Adaptive Biotechnologies

How many people work at Adaptive Biotechnologies?

About 624, which puts Adaptive Biotechnologies in the 501 to 1,000 employee band. The number is from its annual report (10-K) to the SEC for the year ended December 31, 2025.

Where is Adaptive Biotechnologies headquartered?

Adaptive Biotechnologies is headquartered in Seattle, WA. Source: SEC EDGAR.

When was Adaptive Biotechnologies founded?

Adaptive Biotechnologies was founded in 2009. Source: Wikidata.

Is Adaptive Biotechnologies a public company?

Yes. It is listed on Nasdaq as ADPT and files annual reports with the SEC.

What is Adaptive Biotechnologies's revenue?

$277 million for the fiscal year ended December 31, 2025. Source: SEC EDGAR.

What industry is Adaptive Biotechnologies in?

Adaptive Biotechnologies is in biotech and pharma. Source: Wikidata and the SEC's industry code.

Find the decision makers at Adaptive Biotechnologies

Rocketship finds them by title, researches them, emails them from your own Gmail, follows up and books the meeting.

7-day free trial on every monthly plan. Card required.

Facts on this page come from the company's website, Wikidata, and SEC EDGAR, as they stood on November 17, 2026. Wikidata is CC0; SEC filings are public domain; the website is the company's own public home page. The logo is the company’s own, taken from its website, and belongs to its owner. No people are listed. Adaptive Biotechnologies is a trademark of its owner. This page is not made or endorsed by Adaptive Biotechnologies.